Cardiovascular • May 1-3, 2017
Boston, MA • United States



Robert Bradway

CEO, Amgen

Michael Mahoney

CEO, Boston Scientific

George Barrett

CEO, Cardinal Health

Omar Ishrak, PhD

CEO, Medtronic

John Lechleiter, PhD

Chairman, Eli Lilly and Company

John Flannery

CEO, GE Healthcare

Frans van Houten

CEO, Philips

Michael Mussallem

CEO, Edwards Lifesciences

Timothy Ring

CEO, Bard

Tony Coles, MD

CEO, Yumanity Therapeutics

Jessica Mega, MD

CMO, Verily

Nancy Brown

CEO, American Heart Association

Gary Gibbons, MD

Director, NHLBI

Sue Siegel

CEO, GE Ventures & healthymagination

Bernd Montag, PhD

CEO, Siemens Healthcare

Jonathan Rennert

CEO, Zoll Medical

Michael Minogue

CEO, Abiomed

Stéphane Bancel

CEO, Moderna

Robert Califf, MD

Commissioner (former), Food and Drug Administration

Tamara Syrek Jensen

Director, Coverage and Analysis Group, CMS

Elizabeth Nabel, MD

President, Brigham Health

Professor of Medicine, Harvard Medical School

Paul Fonteyne

CEO, Boehringer Ingelheim USA

Richard Migliori, MD

EVP Medical Affairs and CMO, UnitedHealth Group

Paul LaViolette

Managing Partner & COO, SV Life Sciences Advisers

Michael Jaff, DO

President, Newton-Wellesley Hospital, Partners Healthcare

Professor of Medicine, Harvard Medical School

Ora Pescovitz, MD

SVP and US Medical Leader, Eli Lilly and Company

Jean-François Formela, MD

Partner, Atlas Venture

Joseph Loscalzo, MD, PhD

Chairman, Department of Medicine, Physician-in-Chief, Brigham and Women's Hospital

Hersey Professor of the Theory and Practice of Medicine, Soma Weiss, MD Distinguished Chair in Medicine, Harvard Medical School

Katrina Armstrong, MD

Physician-in-Chief, Department of Medicine, Massachusetts General Hospital

Jackson Professor of Clinical Medicine, Harvard Medical School

Jeff Mirviss

SVP and President, Peripheral Interventions, Boston Scientific

Tassos Gianakakos

CEO, MyoKardia

Featured Speakers

Note: speakers are subject to change.